Cargando…
Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression
HER2 is a transmembrane receptor with intrinsic tyrosine kinase activity that is overexpressed in almost 25% of human breast cancers. Here, we report that the neddylation of HER2 is a new post-translational modification that controls its expression and oncogenic activity in human breast cancer. Two...
Autores principales: | Xia, Xiaohong, Hu, Tumei, He, Xiaoyue, Liu, Yuan, Yu, Cuifu, Kong, Weiyao, Liao, Yuning, Tang, Daolin, Liu, Jinbao, Huang, Hongbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830515/ https://www.ncbi.nlm.nih.gov/pubmed/36632463 http://dx.doi.org/10.7150/ijbs.75852 |
Ejemplares similares
-
Selective degradation of AR-V7 to overcome castration resistance of prostate cancer
por: Liu, Yuan, et al.
Publicado: (2021) -
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
por: Xia, Xiaohong, et al.
Publicado: (2021) -
USP10 deletion inhibits macrophage-derived foam cell formation and cellular-oxidized low density lipoprotein uptake by promoting the degradation of CD36
por: Xia, Xiaohong, et al.
Publicado: (2020) -
USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells
por: Liao, Yuning, et al.
Publicado: (2021) -
Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment
por: Xia, Xiaohong, et al.
Publicado: (2020)